Qube Research & Technologies (QRT)’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-248,408	Closed	-$16.9M	–	3217
2022 Q3	$16.9M	Buy	+248,408	New	+$13.7M	0.1%	276
2021 Q3	–	Sell	-20,438	Closed	-$716K	–	2985
2021 Q2	$716K	Buy	+20,438	New	+$798K	0.01%	1092
2020 Q3	–	Sell	-53,161	Closed	-$3.36M	–	2225
2020 Q2	$3.36M	Buy	+53,161	New	+$3.65M	0.05%	487
2020 Q1	–	Sell	-5,692	Closed	-$452K	–	1813
2019 Q4	$452K	Buy	+5,692	New	+$337K	0.01%	1004

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GBT Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 248,408 shares — an estimated $16.9M sold.

Qube Research & Technologies (QRT) first reported a position in GBT in Q4 2019 and held it in 4 quarters. The position peaked at $16.9M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Qube Research & Technologies (QRT) reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 248,408 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $16.9M.
Qube Research & Technologies (QRT) first reported a position in Global Blood Therapeutics, Inc. in Q4 2019 and held it in 4 quarters.
Qube Research & Technologies (QRT)'s Global Blood Therapeutics, Inc. position peaked at $16.9M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.